| 000 | 01365 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514164159.0 | ||
| 264 | 0 | _c20040322 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1354-3784 | ||
| 024 | 7 |
_a10.1517/13543784.13.1.39 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEastham, James A | |
| 245 | 0 | 0 |
_aMultimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cJan 2004 |
||
| 300 |
_a39-46 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatectomy _xmethods |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk Assessment |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 13 _gno. 1 _gp. 39-46 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.13.1.39 _zAvailable from publisher's website |
| 999 |
_c14412677 _d14412677 |
||